Influenza 6:2 reassortant vaccine candidates (3)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza 6:2 reassortant vaccine candidates (3), covering 2016-11-28 to 2016-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season [Phase 4]